Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.

Chang M, Dalvin LA, Mazloumi M, Martin A, Yaghy A, Yang X, Bakhtiari S, Li L, Jennings E, Mashayekhi A, Shields CL.

Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb;9(1):29-38. doi: 10.1097/APO.0000000000000271.

PMID:
31990743
2.

Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.

Chang M, Dalvin LA, Mazloumi M, Martin A, Yaghy A, Yang X, Bakhtiari S, Li L, Jennings E, Mashayekhi A, Shields CL.

Asia Pac J Ophthalmol (Phila). 2020 Jan 14. doi: 10.1097/APO.0000000000000271. [Epub ahead of print]

PMID:
31972749
3.

Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture.

Shields CL, Khoo CTL, Mazloumi M, Mashayekhi A, Shields JA.

Ophthalmol Retina. 2019 Oct 28. pii: S2468-6530(19)30604-9. doi: 10.1016/j.oret.2019.10.009. [Epub ahead of print]

PMID:
31953111
4.

Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.

Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Porcu P, Martinez NL, Glass J, Mashayekhi A, Shields CL.

Asia Pac J Ophthalmol (Phila). 2020 Jan 9. doi: 10.1097/APO.0000000000000274. [Epub ahead of print]

PMID:
31923035
5.

BAP1 GERMLINE MUTATION WITH IRIDOCILIOCHOROIDAL MELANOMA AND MALIGNANT PERITONEAL MESOTHELIOMA.

Yaghy A, Lim LA, Mashayekhi A, Shields CL.

Retin Cases Brief Rep. 2019 Dec 31. doi: 10.1097/ICB.0000000000000934. [Epub ahead of print]

PMID:
31895725
6.

CHOROIDAL NEOVASCULAR MEMBRANE AFTER FINE-NEEDLE ASPIRATION BIOPSY OF VITREORETINAL LYMPHOMA.

Mashayekhi A, Mazloumi M, Shields CL, Shields JA.

Retin Cases Brief Rep. 2019 Dec 27. doi: 10.1097/ICB.0000000000000933. [Epub ahead of print]

PMID:
31895085
7.

Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals.

Shields CL, Dalvin LA, Chang M, Mazloumi M, Fortin P, McGarrey M, Martin A, Yaghy A, Yang X, Vichitvejpaisal P, Mashayekhi A, Shields JA.

JAMA Ophthalmol. 2019 Dec 12. doi: 10.1001/jamaophthalmol.2019.5132. [Epub ahead of print]

PMID:
31830238
8.

Ultra-low-dose (boom-boom) radiotherapy for choroidal lymphoma in three consecutive cases.

Yang X, Dalvin LA, Lim LS, Mashayekhi A, Shields JA, Shields CL.

Eur J Ophthalmol. 2019 Nov 24:1120672119888985. doi: 10.1177/1120672119888985. [Epub ahead of print]

PMID:
31760781
9.

Melanocytoma of the optic disk: A review.

Shields JA, Demirci H, Mashayekhi A, Eagle RC Jr, Shields CL.

Indian J Ophthalmol. 2019 Dec;67(12):1949-1958. doi: 10.4103/ijo.IJO_2039_19. Review.

10.

Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases.

Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA, Shields CL.

Saudi J Ophthalmol. 2019 Jul-Sep;33(3):219-228. doi: 10.1016/j.sjopt.2019.07.002. Epub 2019 Jul 16.

11.

Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma.

Dalvin LA, Mashayekhi A, Shields CL.

JAMA Ophthalmol. 2019 Oct 24. doi: 10.1001/jamaophthalmol.2019.4260. [Epub ahead of print] No abstract available.

PMID:
31647497
12.

Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases.

Shields CL, Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA.

Ophthalmol Retina. 2020 Jan;4(1):100-110. doi: 10.1016/j.oret.2019.08.004. Epub 2019 Aug 22.

PMID:
31611094
13.

DIAGNOSTIC CHALLENGES IN NECROTIC UVEAL MELANOMA.

Peddada K, Dalvin LA, Mashayekhi A, Shields CL.

Retin Cases Brief Rep. 2019 Aug 13. doi: 10.1097/ICB.0000000000000913. [Epub ahead of print]

PMID:
31425450
14.

Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients.

Dalvin LA, Zhang Q, Hamershock RA, Chang M, Yu MD, Mashayekhi A, Shields CL.

Br J Ophthalmol. 2019 Aug 13. pii: bjophthalmol-2019-314686. doi: 10.1136/bjophthalmol-2019-314686. [Epub ahead of print]

PMID:
31409650
15.

VITREOUS AND PRERETINAL SEEDING AFTER TRANSVITREAL FINE NEEDLE ASPIRATION BIOPSY OF CHOROIDAL MELANOMA.

Mashayekhi A, Shields CL, Eagle RC Jr, Shields JA.

Retin Cases Brief Rep. 2019 Aug 9. doi: 10.1097/ICB.0000000000000905. [Epub ahead of print]

PMID:
31403972
16.

Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.

Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Mashayekhi A, Shields CL.

Ophthalmol Retina. 2019 Nov;3(11):998-1005. doi: 10.1016/j.oret.2019.05.021. Epub 2019 May 29.

PMID:
31358444
17.

Amelanotic Ciliochoroidal Melanoma in a Patient with Oculocutaneous Albinism.

Sivalingam MD, Dalvin LA, Shields CL, Mashayekhi A, Shields JA.

Ocul Oncol Pathol. 2019 Apr;5(3):182-185. doi: 10.1159/000490913. Epub 2018 Sep 3.

18.

PHOTODYNAMIC THERAPY FOR EXTRAFOVEOLAR CHOROIDAL OSTEOMA.

Mazloumi M, Dalvin LA, Ancona-Lezama D, Mashayekhi A, Shields CL.

Retina. 2019 Apr 2. doi: 10.1097/IAE.0000000000002534. [Epub ahead of print]

PMID:
30950971
19.

Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.

Shields CL, Sioufi K, Srinivasan A, Di Nicola M, Masoomian B, Barna LE, Bekerman VP, Say EAT, Mashayekhi A, Emrich J, Komarnicky L, Shields JA.

JAMA Ophthalmol. 2018 Dec 1;136(12):1325-1333. doi: 10.1001/jamaophthalmol.2018.3881. Erratum in: JAMA Ophthalmol. 2019 Jan 17;:.

20.

Birdshot-like Chorioretinopathy Associated With Pembrolizumab Treatment.

Acaba-Berrocal LA, Lucio-Alvarez JA, Mashayekhi A, Ho AC, Dunn JP, Shields CL.

JAMA Ophthalmol. 2018 Oct 1;136(10):1205-1207. doi: 10.1001/jamaophthalmol.2018.1851. No abstract available.

PMID:
30054605

Supplemental Content

Loading ...
Support Center